Biopolymer Molecular Weight Can Modulate the Wound Healing Efficacy of Multivalent Sonic Hedgehog-Hyaluronic Acid Conjugates.

There is a clinical need for new therapeutics to improve healing of chronic impaired wounds. Thus, we investigated how biopolymer conjugation could be used to improve the wound healing performance of a key growth factor for tissue regeneration: Sonic hedgehog (Shh). We generated two multivalent Shh conjugates (mvShh) using hyaluronic acid with two different MWs, which exhibited equivalent potency and proteolytic protection in vitro. Using db/db diabetic mice, we showed that mvShh made with smaller HyA MW resulted in more rapid and robust neovascularization compared to mvShh made with larger MW HyA. Further, smaller mvShh conjugates resulted in faster wound resolution compared to the unconjugated Shh. This study is the first to show how the wound healing efficacy of multivalent protein-polymer conjugates is sensitive to the polymer MW, and our findings suggest that this parameter could be used to enhance the efficacy of growth factor conjugates.

[1]  S. Yang,et al.  Hyaluronate-Epidermal Growth Factor Conjugate for Skin Wound Healing and Regeneration. , 2016, Biomacromolecules.

[2]  D. Schaffer,et al.  Multivalent hyaluronic acid bioconjugates improve sFlt-1 activity in vitro. , 2016, Biomaterials.

[3]  D. Schaffer,et al.  Multivalent Conjugates of Sonic Hedgehog Accelerate Diabetic Wound Healing. , 2015, Tissue engineering. Part A.

[4]  D. Schaffer,et al.  The effect of multivalent Sonic hedgehog on differentiation of human embryonic stem cells into dopaminergic and GABAergic neurons. , 2014, Biomaterials.

[5]  D. Schaffer,et al.  Multivalent ligands to control stem cell behaviour in vitro and in vivo , 2013, Nature nanotechnology.

[6]  N. Johnson,et al.  Controlled Delivery of Sonic Hedgehog Morphogen and Its Potential for Cardiac Repair , 2013, PloS one.

[7]  R. Kirsner,et al.  Food and Drug Administration (FDA) drug approval end points for chronic cutaneous ulcer studies , 2012, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[8]  S. Yun,et al.  Transdermal delivery of hyaluronic acid -- human growth hormone conjugate. , 2012, Biomaterials.

[9]  D. Schaffer,et al.  Molecular characterization of multivalent bioconjugates by size-exclusion chromatography with multiangle laser light scattering. , 2012, Bioconjugate chemistry.

[10]  Jeffrey D. Voigt,et al.  Hyaluronic acid derivatives and their healing effect on burns, epithelial surgical wounds, and chronic wounds: A systematic review and meta‐analysis of randomized controlled trials , 2012, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[11]  O. Dereure,et al.  Efficacy and safety of hyaluronic acid in treatment of leg ulcers: a double-blind RCT. , 2012, Journal of Wound Care.

[12]  M. Willis,et al.  Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries , 2012, PharmacoEconomics.

[13]  F. Veronese,et al.  The Impact of PEGylation on Biological Therapies , 2012, BioDrugs.

[14]  S. Yoon,et al.  Target specific hyaluronic acid-interferon alpha conjugate for the treatment of hepatitis C virus infection. , 2011, Biomaterials.

[15]  J. Hakim,et al.  Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic mice. , 2010, The Journal of clinical investigation.

[16]  A. Harken,et al.  Application of the chemokine CXCL12 expression plasmid restores wound healing to near normal in a diabetic mouse model. , 2010, The Journal of trauma.

[17]  R. Andriantsitohaina,et al.  Sonic Hedgehog Pathway as a Target for Therapy in Angiogenesis-Related Diseases , 2009 .

[18]  Sharone' Jacobs,et al.  Wound closure and metabolic parameter variability in a db/db mouse model for diabetic ulcers. , 2009, The Journal of surgical research.

[19]  K. Tømmeraas,et al.  The influence of sodium hyaluronate molecular weight on protein content according to Lowry and Coomassie blue assays , 2008 .

[20]  C Simone Fishburn,et al.  The pharmacology of PEGylation: balancing PD with PK to generate novel therapeutics. , 2008, Journal of pharmaceutical sciences.

[21]  Krishanu Saha,et al.  Multivalency of Sonic hedgehog conjugated to linear polymer chains modulates protein potency. , 2008, Bioconjugate chemistry.

[22]  David E. Golan,et al.  Protein therapeutics: a summary and pharmacological classification , 2008, Nature Reviews Drug Discovery.

[23]  J. Hanft,et al.  Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers. , 2008, Journal of wound care.

[24]  N. Boudreau,et al.  Sustained expression of Hif‐1α in the diabetic environment promotes angiogenesis and cutaneous wound repair , 2007, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[25]  M. Moskowitz,et al.  Sonic hedgehog inversely regulates the expression of angiopoietin-1 and angiopoietin-2 in fibroblasts. , 2007, International journal of molecular medicine.

[26]  Jun Asai,et al.  Topical Sonic Hedgehog Gene Therapy Accelerates Wound Healing in Diabetes by Enhancing Endothelial Progenitor Cell–Mediated Microvascular Remodeling , 2006, Circulation.

[27]  Nancy Boudreau,et al.  HOXA3 induces cell migration in endothelial and epithelial cells promoting angiogenesis and wound repair , 2005, Journal of Cell Science.

[28]  I. Mahmood,et al.  Pharmacokinetic and Pharmacodynamic Considerations in the Development of Therapeutic Proteins , 2005, Clinical pharmacokinetics.

[29]  Yihai Cao,et al.  Impaired Angiogenesis, Delayed Wound Healing and Retarded Tumor Growth in Perlecan Heparan Sulfate-Deficient Mice , 2004, Cancer Research.

[30]  C. Myers,et al.  HoxD3 accelerates wound healing in diabetic mice. , 2003, The American journal of pathology.

[31]  N. Boudreau,et al.  HoxD3 expression and collagen synthesis in diabetic fibroblasts , 2003, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[32]  G. Torrance,et al.  Cost-effectiveness of becaplermin for nonhealing neuropathic diabetic foot ulcers. , 2003, Ostomy/wound management.

[33]  Richard B Greenwald,et al.  Effective drug delivery by PEGylated drug conjugates. , 2003, Advanced drug delivery reviews.

[34]  Geoffrey C Gurtner,et al.  Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. , 2003, The American journal of pathology.

[35]  Fred H. Gage,et al.  Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo , 2003, Nature Neuroscience.

[36]  Brian H Annex,et al.  A target‐mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans , 2002, Clinical pharmacology and therapeutics.

[37]  J. McCafferty,et al.  Engineering therapeutic proteins. , 2000, Current opinion in structural biology.

[38]  D. Baker,et al.  Functional antagonists of sonic hedgehog reveal the importance of the N terminus for activity. , 1999, Journal of cell science.

[39]  Thomas A. Mustoe, MD, FACS,et al.  Pharmacologic enhancement of wound healing. , 1995, Annual review of medicine.

[40]  P. Caliceti,et al.  A branched monomethoxypoly(ethylene glycol) for protein modification. , 1995, Bioconjugate chemistry.

[41]  W. Meyer-Ingold,et al.  Wound therapy: growth factors as agents to promote healing. , 1993, Trends in biotechnology.

[42]  J. Harvey,et al.  Fibrinolysis and angiogenesis in wound healing , 1991, The Journal of pathology.

[43]  Yan Feng,et al.  Chemical Modification of Enzyme Molecules to Improve Their Characteristics , 1990, Annals of the New York Academy of Sciences.